Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

AndroScience and Orient Europharma collaborate on topical acne therapy

May 25, 2010

Italy approves use and reimbursement of afamelanotide for erythropoietic protoporphyria

May 18, 2010

Meda acquires European rights from Graceway to new imiquimod formulation for AK

May 17, 2010

NexMed presents preclinical results for Vitaros in wound healing

May 14, 2010

Capstone Therapeutics continues second phase II AZX-100 trial

May 14, 2010

Novel activators of hyaluronan transport disclosed by German scientists

May 7, 2010

Morria Biopharmaceuticals to begin phase II trial of MRX-6

April 23, 2010

Ongoing tacrolimus treatment beneficial for atopic dermatitis

April 21, 2010

Promising phase Ib data on TD-101 in pachyonychia congenita / News in Context

April 15, 2010

PharmaSurgics' phase II PXL-01 trial extended to Denmark

April 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...